Speaker illustration

Professor Francesco Cappuccio

University of Warwick, Coventry (United Kingdom of Great Britain & Northern Ireland)

He is Cephalon Professor of Cardiovascular Medicine & Epidemiology at the University of Warwick and Consultant Cardiovascular Physician at University Hospitals Coventry & Warwickshire NHS Trust. He is Head of the World Health Organization Collaborating Centre for Nutrition and Director of the E.S.H. Centre of Excellence in Hypertension and Cardio-Metabolic Research. He is the Immediate Past-President, British and Irish Hypertension Society. He graduated in Medicine at the Federico II University Medical School in Naples in 1981 and moved to the UK in 1983. He trained in General Medicine (with Cardiovascular and Hypertension) at Charing Cross and St George's Hospitals, and in Public Health in the North Thames Region in London. He obtained a Master in Epidemiology at the London School of Hygiene and Tropical Medicine in 1993 and was awarded a DSc at the University of Warwick in 2012. He holds FRCP, FFPH, FBIHS, FAOP, FAHA and FESC.

Closing remarks and Q&A.

Event: ESC Congress 2022

Topic: Hypertension

Session: Sliding doors in hypertension management

Thumbnail

Hypertension, the silent pandemic that still runs the major clinical and economic burden.

Event: ESC Congress 2022

Topic: Hypertension

Session: Sliding doors in hypertension management

Thumbnail

Sleep and cardio-metabolic risk – a new dimension for prevention and management

Event: ESC CONGRESS 2019

Topic: Diagnostic Methods

Session: Innovative development in watch-type wearable SMART blood pressure monitoring and its clinical application

Thumbnail

Salt: update on impact of salt on CVD burden and global initiatives to lower salt intake.

Event: EuroPrevent 2018

Topic: Physical Inactivity and Exercise

Session: Diet and CVD: what's new?

Thumbnail

Sleep duration and cardiovascular risk: what's the evidence from observational studies?

Event: EuroPrevent 2018

Topic: Epidemiology

Session: Sleep as a risk factor for cardiovascular disease

Thumbnail

This platform is supported by

logo Novo Nordisk